tradingkey.logo
tradingkey.logo
Search

Pasithea Therapeutics Corp

KTTA
Add to Watchlist
0.455USD
-0.025-5.25%
Close 07-24 16:00ETQuotes delayed by 15 min
15.20MMarket Cap
LossP/E TTM

KTTA Financials

See Pasithea Therapeutics Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Pasithea Therapeutics Corp Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.12/-0.45
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.91
77.10%
Analyst Rating
BUY
2026/07/26
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
92.68%-0.12
68.75%-0.79
85.80%-0.41
82.22%-0.66
56.49%-1.61
38.45%-2.53
17.15%-2.87
-28.65%-3.71
-36.48%-3.70
-11.54%-4.12
---3.47
---2.88
---2.71
---3.69
---7.22
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--13.58K
----
--15.06K
----
----
Net Profit
19.47%-2.87M
-218.19%-10.11M
-1.25%-3.04M
3.88%-3.72M
7.71%-3.56M
37.05%-3.18M
16.96%-3.00M
-2.74%-3.87M
-9.13%-3.86M
1.36%-5.05M
21.23%-3.61M
-41.56%-3.76M
-124.72%-3.54M
-912.17%-5.12M
-200.51%-4.59M
-265.19%-2.66M
-186.43%-1.57M
--630.12K
---1.53M
---727.95K
Debt to assets ratio
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.35%
--0.63%
----
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--13.58K
----
--15.06K
----
----
Operating profit
-32.51%-4.88M
-214.65%-10.26M
-3.51%-3.11M
3.40%-3.81M
8.92%-3.68M
36.69%-3.26M
20.71%-3.00M
-3.04%-3.95M
-25.78%-4.04M
-27.36%-5.15M
1.72%-3.79M
-24.30%-3.83M
-54.53%-3.21M
-106.66%-4.04M
-202.74%-3.86M
-323.12%-3.08M
-278.25%-2.08M
---1.96M
---1.27M
---727.95K
Net Profit
19.47%-2.87M
-218.19%-10.11M
-1.25%-3.04M
3.88%-3.72M
7.71%-3.56M
37.05%-3.18M
16.96%-3.00M
-2.74%-3.87M
-9.13%-3.86M
1.36%-5.05M
21.23%-3.61M
-41.56%-3.76M
-124.72%-3.54M
-912.17%-5.12M
-200.51%-4.59M
-265.19%-2.66M
-186.43%-1.57M
--630.12K
---1.53M
---727.95K
Current assets
760.93%52.73M
666.24%56.46M
-43.46%5.53M
-0.07%8.64M
-53.57%6.12M
-55.86%7.37M
-52.92%9.78M
-69.17%8.64M
-57.60%13.19M
-51.02%16.69M
-53.29%20.77M
-42.33%28.04M
-38.93%31.11M
-36.07%34.08M
111.42%44.47M
5156.97%48.61M
4368.80%50.95M
--53.30M
--21.03M
--924.76K
Total current liabilities
-6.61%1.49M
344.15%4.97M
108.53%1.38M
24.53%1.74M
-35.35%1.59M
-57.48%1.12M
-67.69%660.40K
-37.42%1.39M
16.25%2.47M
40.29%2.63M
35.00%2.04M
134.61%2.23M
389.33%2.12M
319.79%1.88M
186.69%1.51M
108.96%950.11K
81.11%433.68K
--447.28K
--528.10K
--454.68K
Total assets
284.44%56.35M
274.98%60.24M
-26.86%13.63M
-3.70%17.01M
-34.58%14.66M
-38.49%16.06M
-39.21%18.64M
-53.70%17.66M
-46.70%22.41M
-42.19%26.12M
-38.20%30.66M
-28.06%38.15M
-17.69%42.04M
-15.27%45.18M
135.75%49.61M
5634.22%53.03M
4380.08%51.08M
--53.32M
--21.04M
--924.76K
Total liabilities
-8.20%1.54M
291.63%5.02M
72.82%1.42M
23.02%1.83M
-33.45%1.68M
-52.84%1.28M
-63.92%823.98K
-41.85%1.49M
-13.24%2.52M
1.36%2.72M
-19.00%2.28M
64.67%2.56M
164.24%2.91M
41.14%2.68M
-38.27%2.82M
241.81%1.55M
359.88%1.10M
--1.90M
--4.57M
--454.68K
Total equity
322.32%54.81M
273.54%55.22M
-31.47%12.21M
-6.16%15.18M
-34.73%12.98M
-36.82%14.78M
-37.22%17.81M
-54.55%16.18M
-49.19%19.88M
-44.94%23.40M
-39.36%28.37M
-30.86%35.59M
-21.69%39.14M
-17.35%42.50M
184.00%46.79M
10850.00%51.47M
5448.90%49.98M
--51.42M
--16.48M
--470.08K
Net operating income
44.27%-1.70M
-120.91%-5.40M
7.38%-2.89M
4.21%-3.87M
29.28%-3.06M
25.84%-2.44M
3.63%-3.12M
-31.15%-4.04M
-34.94%-4.32M
-3.42%-3.29M
14.90%-3.24M
-29.56%-3.08M
-26.70%-3.20M
-82.61%-3.19M
-593.72%-3.80M
-375.94%-2.38M
-561.91%-2.53M
---1.74M
---548.44K
---499.44K
Net investment
----
--11.00K
----
----
----
----
-100.00%0.00
-100.00%0.00
100.00%0.00
102.33%54.54K
-57.25%50.16K
-37.05%24.39K
52.67%-53.89K
-18007.96%-2.34M
1468.96%117.32K
--38.75K
---113.87K
---12.93K
---8.57K
----
Net financing
-99.95%750.00
239682.21%56.42M
-102.56%-116.14K
--5.74M
--1.47M
---23.55K
217.65%4.54M
100.00%0.00
-100.00%0.00
100.00%0.00
---3.86M
---130.77K
--264.10K
-109.38%-3.21M
-100.00%0.00
--0.00
-100.00%0.00
--34.17M
--20.55M
--0.00

FAQs

What are the current assets of Pasithea Therapeutics Corp?

According to Pasithea Therapeutics Corp's FY2025 earnings report, its current assets were 56.46M, with a year-on-year change of 666.24.

What are the total assets of Pasithea Therapeutics Corp?

According to Pasithea Therapeutics Corp's FY2025 earnings report, its total assets of Pasithea Therapeutics Corp were 60.24M, with a year-on-year change of 274.98.

What are the total liabilities of Pasithea Therapeutics Corp?

According to Pasithea Therapeutics Corp's FY2025 earnings report, its total liabilities of Pasithea Therapeutics Corp were 5.02M, with a year-on-year change of 291.63.

What is the total equity of Pasithea Therapeutics Corp?

According to Pasithea Therapeutics Corp's FY2025 earnings report, its total equity of Pasithea Therapeutics Corp was 55.22M, with a year-on-year change of 273.54.

What is the net operating income of Pasithea Therapeutics Corp?

According to Pasithea Therapeutics Corp's FY2025 earnings report, its net operating income of Pasithea Therapeutics Corp was -20.86M, with a year-on-year change of -46.37.

What is the net financing of Pasithea Therapeutics Corp?

According to Pasithea Therapeutics Corp's FY2025 earnings report, its net financing of Pasithea Therapeutics Corp was 63.52M, with a year-on-year change of 1306.02.

What is the Earnings Per Share (EPS) of Pasithea Therapeutics Corp?

According to Pasithea Therapeutics Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -2.91, with a year-on-year change of 77.10.

What is the net income of Pasithea Therapeutics Corp?

According to Pasithea Therapeutics Corp's FY2025 earnings report, its net income was -20.43M, with a year-on-year change of -46.91.

What is the Return on Equity (ROE) of Pasithea Therapeutics Corp?

According to Pasithea Therapeutics Corp's FY2025 earnings report, its Return on Equity (ROE) was -58.36, with a year-on-year change of 19.87.

What is the Return on Assets (ROA) of Pasithea Therapeutics Corp?

According to Pasithea Therapeutics Corp's FY2025 earnings report, its Return on Assets (ROA) was -53.54, with a year-on-year change of 18.79.

What is the operating profit of Pasithea Therapeutics Corp?

According to Pasithea Therapeutics Corp's FY2025 earnings report, its operating profit was -20.86M, with a year-on-year change of -46.37.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.